Benzenesulfonyl chloride → 4,4-Dimethyl-1-(phenylsulfonyl)-2-(adamantan-2-yl)-1,2-diazetidin-3-one
Reaktionsgleichung
[CH:1]12[CH2:10][CH:5]3[CH2:6][CH:7]([CH2:9][CH:3]([CH2:4]3)[CH:2]1[N:11]1[C:14](=[O:15])[C:13]([CH3:17])([CH3:16])[NH:12]1)[CH2:8]2.[C:18]1([S:24](Cl)(=[O:26])=[O:25])[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1>>[CH3:16][C:13]1([CH3:17])[N:12]([S:24]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)(=[O:26])=[O:25])[N:11]([CH:2]2[CH:3]3[CH2:4][CH:5]4[CH2:6][CH:7]([CH2:8][CH:1]2[CH2:10]4)[CH2:9]3)[C:14]1=[O:15]Komponenten
3
Versuchsvorschrift
2-(Adamantan-2-yl)-4,4-dimethyl-1,2-diazetidin-3-one and benzene sulfonyl chloride were used for a similar reaction and treatment as Example 169, and the title compound was obtained as a colorless crystalline powder.
Quellen und Nachweise
- ORD-Eintrag
- ord-2755c4cc5d78424898beeb0577e2d991
- Quelldatensatz
- uspto-grants-2012_08
- Patentnummer
- US08252781B2
Notizen zur Reaktion
Wird geladen…